Imbruvica
Brand Name: Imbruvica
Generic Name: Ibrutinib
Active
Registration Number
DR-XY48674
Dosage Form
Film-Coated Tablet
Issuance Date
September 28, 2023
Expiry Date
March 30, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength420 mg
PackagingPVC/PCTFE/Alu Blister Pack x 14’s
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic Agent (Protein Kinase Inhibitor)
A
Application
Monitored Release (Correction)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
IbrutinibActive
Monograph: Ibrutinib